Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 797,799 | 65,442 | N/A | 54,147 | 46,464 |
| Marketable Securities | 2,295 | 2,201 | N/A | N/A | N/A |
| Receivables | 112,140 | 88,244 | N/A | 65,310 | 72,984 |
| Inventories | 63,625 | 39,572 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 78,992 | 393,522 |
| TOTAL | $997,800 | $215,729 | $N/A | $214,662 | $520,819 |
| Non-Current Assets | |||||
| PPE Net | 63,170 | 67,817 | N/A | 1,781,321 | 1,820,735 |
| Investments And Advances | 0 | 0 | 0 | 550,573 | 495,488 |
| Intangibles | 19,344 | 19,344 | 0 | 0 | 0 |
| Other Non-Current Assets | 45,349 | 40,844 | 0 | 66,076 | 64,723 |
| TOTAL | $127,863 | $128,005 | $N/A | $2,397,970 | $2,380,946 |
| Total Assets | $1,125,663 | $343,734 | $N/A | $2,612,632 | $2,901,765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 169 | 60,090 | N/A | 183,448 | 218,094 |
| Accounts payable and accrued liabilities | 39,206 | 27,791 | 0 | 104,175 | 29,671 |
| Accrued Expenses | 87,770 | 77,542 | N/A | 29,598 | 25,206 |
| Other current liabilities | N/A | N/A | N/A | N/A | 8,752 |
| TOTAL | $127,145 | $165,423 | $N/A | $320,250 | $288,128 |
| Non-Current Liabilities | |||||
| Long Term Debt | 378,823 | 319,438 | N/A | 1,562,283 | 1,880,122 |
| Deferred Revenues | N/A | N/A | N/A | 3,029 | 6,405 |
| Other Non-Current Liabilities | 42,388 | 2,357,711 | 0 | 3,417 | 4,899 |
| TOTAL | $421,211 | $2,677,149 | $N/A | $1,590,142 | $1,920,397 |
| Total Liabilities | $548,356 | $2,842,572 | $N/A | $1,910,392 | $2,208,525 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 282,580 | N/A | N/A | 17,285 | 17,487 |
| Common Shares | 283 | 38 | N/A | 2 | 2 |
| Retained earnings | -2,548,736 | -2,472,300 | N/A | 503,321 | 493,294 |
| Other shareholders' equity | 1,040 | -26,576 | 0 | 98,122 | 97,235 |
| TOTAL | $577,307 | $-2,498,838 | $N/A | $702,240 | $693,240 |
| Total Liabilities And Equity | $1,125,663 | $343,734 | $0 | $2,612,632 | $2,901,765 |